ICD 9 Range MALIGNANT NEOPLASM OF LYMPHATIC AND HEMATOPOIETIC TISSUE

• 1  Lymphosarcoma and reticulosarcoma     ( 200 )

• 2  Reticulosarcoma     ( 200.0 )

• 3  Reticulosarcoma unspecified site     ( 200.00 )

• 4  Reticulosarcoma involving lymph nodes of head face and neck     ( 200.01 )

• 5  Reticulosarcoma involving intrathoracic lymph nodes     ( 200.02 )

• 6  Reticulosarcoma involving intra-abdominal lymph nodes     ( 200.03 )

• 7  Reticulosarcoma involving lymph nodes of axilla and upper limb     ( 200.04 )

• 8  Reticulosarcoma involving lymph nodes of inguinal region and lower limb     ( 200.05 )

• 9  Reticulosarcoma involving intrapelvic lymph nodes     ( 200.06 )

• 10  Reticulosarcoma involving spleen     ( 200.07 )

• 11  Reticulosarcoma involving lymph nodes of multiple sites     ( 200.08 )

• 12  Lymphosarcoma     ( 200.1 )

• 13  Lymphosarcoma unspecified site     ( 200.10 )

• 14  Lymphosarcoma involving lymph nodes of head face and neck     ( 200.11 )

• 15  Lymphosarcoma involving intrathoracic lymph nodes     ( 200.12 )

• 16  Lymphosarcoma involving intra-abdominal lymph nodes     ( 200.13 )

• 17  Lymphosarcoma involving lymph nodes of axilla and upper limb     ( 200.14 )

• 18  Lymphosarcoma involving lymph nodes of inguinal region and lower limb     ( 200.15 )

• 19  Lymphosarcoma involving intrapelvic lymph nodes     ( 200.16 )

• 20  Lymphosarcoma involving spleen     ( 200.17 )

• 21  Lymphosarcoma involving lymph nodes of multiple sites     ( 200.18 )

• 22  Burkitt's tumor or lymphoma     ( 200.2 )

• 23  Burkitt's tumor or lymphoma unspecified site     ( 200.20 )

• 24  Burkitt's tumor or lymphoma involving lymph nodes of head face and neck     ( 200.21 )

• 25  Burkitt's tumor or lymphoma involving intrathoracic lymph nodes     ( 200.22 )

• 26  Burkitt's tumor or lymphoma involving intra-abdominal lymph nodes     ( 200.23 )

• 27  Burkitt's tumor or lymphoma involving lymph nodes of axilla and upper limb     ( 200.24 )

• 28  Burkitt's tumor or lymphoma involving lymph nodes of inguinal region and lower limb     ( 200.25 )

• 29  Burkitt's tumor or lymphoma involving intrapelvic lymph nodes     ( 200.26 )

• 30  Burkitt's tumor or lymphoma involving spleen     ( 200.27 )

• 31  Burkitt's tumor or lymphoma involving lymph nodes of multiple sites     ( 200.28 )

• 32  Lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue : Marginal zone lymphoma     ( 200.3 )

• 33  Marginal zone lymphoma, unspecified site, extranodal and solid organ sites     ( 200.30 )

• 34  Marginal zone lymphoma,lymph nodes of head, face, and neck     ( 200.31 )

• 35  Marginal zone lymphoma,intrathoracic lymph nodes     ( 200.32 )

• 36  Marginal zone lymphoma, intraabdominal lymph nodes     ( 200.33 )

• 37  Marginal zone lymphoma, lymph nodes of axilla and upper limb     ( 200.34 )

• 38  Marginal zone lymphoma, lymph nodes of inguinal region and lower limb     ( 200.35 )

• 39  Marginal zone lymphoma, intrapelvic lymph nodes     ( 200.36 )

• 40  Marginal zone lymphoma, spleen     ( 200.37 )

• 41  Marginal zone lymphoma, lymph nodes of multiple sites     ( 200.38 )

• 42  Lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue : Mantle cell lymphoma     ( 200.4 )

• 43  Mantle cell lymphoma, unspecified site, extranodal and solid organ sites     ( 200.40 )

• 44  Mantle cell lymphoma, lymph nodes of head, face, and neck     ( 200.41 )

• 45  Mantle cell lymphoma, intrathoracic lymph nodes     ( 200.42 )

• 46  Mantle cell lymphoma, intra-abdominal lymph nodes     ( 200.43 )

• 47  Mantle cell lymphoma, lymph nodes of axilla and upper limb     ( 200.44 )

• 48  Mantle cell lymphoma, lymph nodes of inguinal region and lower limb     ( 200.45 )

• 49  Mantle cell lymphoma, intrapelvic lymph nodes     ( 200.46 )

• 50  Mantle cell lymphoma, spleen     ( 200.47 )

• 51  Mantle cell lymphoma, lymph nodes of multiple sites     ( 200.48 )

• 52  Lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue : Primary central nervous system lymphoma     ( 200.5 )

• 53  Primary central nervous system lymphoma, unspecified site, extranodal and solid organ sites     ( 200.50 )

• 54  Primary central nervous system lymphoma, lymph nodes of head, face, and neck     ( 200.51 )

• 55  Primary central nervous system lymphoma, intrathoracic lymph nodes     ( 200.52 )

• 56  Primary central nervous system lymphoma, intra-abdominal lymph nodes     ( 200.53 )

• 57  Primary central nervous system lymphoma, lymph nodes of axilla and upper limb     ( 200.54 )

• 58  Primary central nervous system lymphoma, lymph nodes of inguinal region and lower limb     ( 200.55 )

• 59  Primary central nervous system lymphoma, intrapelvic lymph nodes     ( 200.56 )

• 60  Primary central nervous system lymphoma, spleen     ( 200.57 )

• 61  Primary central nervous system lymphoma, lymph nodes of multiple sites     ( 200.58 )

• 62  Lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue : Anaplastic large cell lymphoma     ( 200.6 )

• 63  Anaplastic large cell lymphoma, unspecified site, extranodal and solid organ sites     ( 200.60 )

• 64  Anaplastic large cell lymphoma, lymph nodes of head, face, and neck     ( 200.61 )

• 65  Anaplastic large cell lymphoma, intrathoracic lymph nodes     ( 200.62 )

• 66  Anaplastic large cell lymphoma, intra-abdominal lymph nodes     ( 200.63 )

• 67  Anaplastic large cell lymphoma, lymph nodes of axilla and upper limb     ( 200.64 )

• 68  Anaplastic large cell lymphoma, lymph nodes of inguinal region and lower limb     ( 200.65 )

• 69  Anaplastic large cell lymphoma, intrapelvic lymph nodes     ( 200.66 )

• 70  Anaplastic large cell lymphoma, spleen     ( 200.67 )

• 71  Anaplastic large cell lymphoma, lymph nodes of multiple sites     ( 200.68 )

• 72  Lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue : Large cell lymphoma     ( 200.7 )

• 73  Large cell lymphoma, unspecified site, extranodal and solid organ sites     ( 200.70 )

• 74  Large cell lymphoma, lymph nodes of head, face, and neck     ( 200.71 )

• 75  Large cell lymphoma, intrathoracic lymph nodes     ( 200.72 )

• 76  Large cell lymphoma, intra-abdominal lymph nodes     ( 200.73 )

• 77  Large cell lymphoma, lymph nodes of axilla and upper limb     ( 200.74 )

• 78  Large cell lymphoma, lymph nodes of inguinal region and lower limb     ( 200.75 )

• 79  Large cell lymphoma, intrapelvic lymph nodes     ( 200.76 )

• 80  Large cell lymphoma, spleen     ( 200.77 )

• 81  Large cell lymphoma, lymph nodes of multiple sites     ( 200.78 )

• 82  Other named variants of lymphosarcoma and reticulosarcoma     ( 200.8 )

• 83  Other named variants of lymphosarcoma and reticulosarcoma unspecified site     ( 200.80 )

• 84  Other named variants of lymphosarcoma and reticulosarcoma involving lymph nodes of head face and neck     ( 200.81 )

• 85  Other named variants of lymphosarcoma and reticulosarcoma involving intrathoracic lymph nodes     ( 200.82 )

• 86  Other named variants of lymphosarcoma and reticulosarcoma involving intra-abdominal lymph nodes     ( 200.83 )

• 87  Other named variants of lymphosarcoma and reticulosarcoma involving lymph nodes of axilla and upper limb     ( 200.84 )

• 88  Other named variants of lymphosarcoma and reticulosarcoma involving lymph nodes of inguinal region and lower limb     ( 200.85 )

• 89  Other named variants of lymphosarcoma and reticulosarcoma involving intrapelvic lymph nodes     ( 200.86 )

• 90  Other named variants of lymphosarcoma and reticulosarcoma involving spleen     ( 200.87 )

• 91  Other named variants of lymphosarcoma and reticulosarcoma involving lymph nodes of multiple sites     ( 200.88 )

• 92  Hodgkin's disease     ( 201 )

• 93  Hodgkin's paragranuloma     ( 201.0 )

• 94  Hodgkin's paragranuloma unspecified site     ( 201.00 )

• 95  Hodgkin's paragranuloma involving lymph nodes of head face and neck     ( 201.01 )

• 96  Hodgkin's paragranuloma involving intrathoracic lymph nodes     ( 201.02 )

• 97  Hodgkin's paragranuloma involving intra-abdominal lymph nodes     ( 201.03 )

• 98  Hodgkin's paragranuloma involving lymph nodes of axilla and upper limb     ( 201.04 )

• 99  Hodgkin's paragranuloma involving lymph nodes of inguinal region and lower limb     ( 201.05 )

• 100  Hodgkin's paragranuloma involving intrapelvic lymph nodes     ( 201.06 )

• 101  Hodgkin's paragranuloma involving spleen     ( 201.07 )

• 102  Hodgkin's paragranuloma involving lymph nodes of multiple sites     ( 201.08 )

• 103  Hodgkin's granuloma     ( 201.1 )

• 104  Hodgkin's granuloma unspecified site     ( 201.10 )

• 105  Hodgkin's granuloma involving lymph nodes of head face and neck     ( 201.11 )

• 106  Hodgkin's granuloma involving intrathoracic lymph nodes     ( 201.12 )

• 107  Hodgkin's granuloma involving intra-abdominal lymph nodes     ( 201.13 )

• 108  Hodgkin's granuloma involving lymph nodes of axilla and upper limb     ( 201.14 )

• 109  Hodgkin's granuloma involving lymph nodes of inguinal region and lower limb     ( 201.15 )

• 110  Hodgkin's granuloma involving intrapelvic lymph nodes     ( 201.16 )

• 111  Hodgkin's granuloma involving spleen     ( 201.17 )

• 112  Hodgkin's granuloma involving lymph nodes of multiple sites     ( 201.18 )

• 113  Hodgkin's sarcoma     ( 201.2 )

• 114  Hodgkin's sarcoma unspecified site     ( 201.20 )

• 115  Hodgkin's sarcoma involving lymph nodes of head face and neck     ( 201.21 )

• 116  Hodgkin's sarcoma involving intrathoracic lymph nodes     ( 201.22 )

• 117  Hodgkin's sarcoma involving intra-abdominal lymph nodes     ( 201.23 )

• 118  Hodgkin's sarcoma involving lymph nodes of axilla and upper limb     ( 201.24 )

• 119  Hodgkin's sarcoma involving lymph nodes of inguinal region and lower limb     ( 201.25 )

• 120  Hodgkin's sarcoma involving intrapelvic lymph nodes     ( 201.26 )

• 121  Hodgkin's sarcoma involving spleen     ( 201.27 )

• 122  Hodgkin's sarcoma involving lymph nodes of multiple sites     ( 201.28 )

• 123  Hodgkin's disease lymphocytic-histiocytic predominance     ( 201.4 )

• 124  Hodgkin's disease lymphocytic-histiocytic predominance unspecified site     ( 201.40 )

• 125  Hodgkin's disease lymphocytic-histiocytic predominance involving lymph nodes of head face and neck     ( 201.41 )

• 126  Hodgkin's disease lymphocytic-histiocytic predominance involving intrathoracic lymph nodes     ( 201.42 )

• 127  Hodgkin's disease lymphocytic-histiocytic predominance involving intra-abdominal lymph nodes     ( 201.43 )

• 128  Hodgkin's disease lymphocytic-histiocytic predominance involving lymph nodes of axilla and upper limb     ( 201.44 )

• 129  Hodgkin's disease lymphocytic-histiocytic predominance involving lymph nodes of inguinal region and lower limb     ( 201.45 )

• 130  Hodgkin's disease lymphocytic-histiocytic predominance involving intrapelvic lymph nodes     ( 201.46 )

• 131  Hodgkin's disease lymphocytic-histiocytic predominance involving spleen     ( 201.47 )

• 132  Hodgkin's disease lymphocytic-histiocytic predominance involving lymph nodes of multiple sites     ( 201.48 )

• 133  Hodgkin's disease nodular sclerosis     ( 201.5 )

• 134  Hodgkin's disease nodular sclerosis unspecified site     ( 201.50 )

• 135  Hodgkin's disease nodular sclerosis involving lymph nodes of head face and neck     ( 201.51 )

• 136  Hodgkin's disease nodular sclerosis involving intrathoracic lymph nodes     ( 201.52 )

• 137  Hodgkin's disease nodular sclerosis involving intra-abdominal lymph nodes     ( 201.53 )

• 138  Hodgkin's disease nodular sclerosis involving lymph nodes of axilla and upper limb     ( 201.54 )

• 139  Hodgkin's disease nodular sclerosis involving lymph nodes of inguinal region and lower limb     ( 201.55 )

• 140  Hodgkin's disease nodular sclerosis involving intrapelvic lymph nodes     ( 201.56 )

• 141  Hodgkin's disease nodular sclerosis involving spleen     ( 201.57 )

• 142  Hodgkin's disease nodular sclerosis involving lymph nodes of multiple sites     ( 201.58 )

• 143  Hodgkin's disease mixed cellularity     ( 201.6 )

• 144  Hodgkin's disease mixed cellularity unspecified site     ( 201.60 )

• 145  Hodgkin's disease mixed cellularity involving lymph nodes of head face and neck     ( 201.61 )

• 146  Hodgkin's disease mixed cellularity involving intrathoracic lymph nodes     ( 201.62 )

• 147  Hodgkin's disease mixed cellularity involving intra-abdominal lymph nodes     ( 201.63 )

• 148  Hodgkin's disease mixed cellularity involving lymph nodes of axilla and upper limb     ( 201.64 )

• 149  Hodgkin's disease mixed cellularity involving lymph nodes of inguinal region and lower limb     ( 201.65 )

• 150  Hodgkin's disease mixed cellularity involving intrapelvic lymph nodes     ( 201.66 )

• 151  Hodgkin's disease mixed cellularity involving spleen     ( 201.67 )

• 152  Hodgkin's disease mixed cellularity involving lymph nodes of multiple sites     ( 201.68 )

• 153  Hodgkin's disease lymphocytic depletion     ( 201.7 )

• 154  Hodgkin's disease lymphocytic depletion unspecified site     ( 201.70 )

• 155  Hodgkin's disease lymphocytic depletion involving lymph nodes of head face and neck     ( 201.71 )

• 156  Hodgkin's disease lymphocytic depletion involving intrathoracic lymph nodes     ( 201.72 )

• 157  Hodgkin's disease lymphocytic depletion involving intra-abdominal lymph nodes     ( 201.73 )

• 158  Hodgkin's disease lymphocytic depletion involving lymph nodes of axilla and upper limb     ( 201.74 )

• 159  Hodgkin's disease lymphocytic depletion involving lymph nodes of inguinal region and lower limb     ( 201.75 )

• 160  Hodgkin's disease lymphocytic depletion involving intrapelvic lymph nodes     ( 201.76 )

• 161  Hodgkin's disease lymphocytic depletion involving spleen     ( 201.77 )

• 162  Hodgkin's disease lymphocytic depletion involving lymph nodes of multiple sites     ( 201.78 )

• 163  Hodgkin's disease unspecified type     ( 201.9 )

• 164  Hodgkin's disease unspecified type unspecified site     ( 201.90 )

• 165  Hodgkin's disease unspecified type involving lymph nodes of head face and neck     ( 201.91 )

• 166  Hodgkin's disease unspecified type involving intrathoracic lymph nodes     ( 201.92 )

• 167  Hodgkin's disease unspecified type involving intra-abdominal lymph nodes     ( 201.93 )

• 168  Hodgkin's disease unspecified type involving lymph nodes of axilla and upper limb     ( 201.94 )

• 169  Hodgkin's disease unspecified type involving lymph nodes of inguinal region and lower limb     ( 201.95 )

• 170  Hodgkin's disease unspecified type involving intrapelvic lymph nodes     ( 201.96 )

• 171  Hodgkin's disease unspecified type involving spleen     ( 201.97 )

• 172  Hodgkin's disease unspecified type involving lymph nodes of multiple sites     ( 201.98 )

• 173  Other malignant neoplasms of lymphoid and histiocytic tissue     ( 202 )

• 174  Nodular lymphoma     ( 202.0 )

• 175  Nodular lymphoma unspecified site     ( 202.00 )

• 176  Nodular lymphoma involving lymph nodes of head face and neck     ( 202.01 )

• 177  Nodular lymphoma involving intrathoracic lymph nodes     ( 202.02 )

• 178  Nodular lymphoma involving intra-abdominal lymph nodes     ( 202.03 )

• 179  Nodular lymphoma involving lymph nodes of axilla and upper limb     ( 202.04 )

• 180  Nodular lymphoma involving lymph nodes of inguinal region and lower limb     ( 202.05 )

• 181  Nodular lymphoma involving intrapelvic lymph nodes     ( 202.06 )

• 182  Nodular lymphoma involving spleen     ( 202.07 )

• 183  Nodular lymphoma involving lymph nodes of multiple sites     ( 202.08 )

• 184  Mycosis fungoides     ( 202.1 )

• 185  Mycosis fungoides unspecified site     ( 202.10 )

• 186  Mycosis fungoides involving lymph nodes of head face and neck     ( 202.11 )

• 187  Mycosis fungoides involving intrathoracic lymph nodes     ( 202.12 )

• 188  Mycosis fungoides involving intra-abdominal lymph nodes     ( 202.13 )

• 189  Mycosis fungoides involving lymph nodes of axilla and upper limb     ( 202.14 )

• 190  Mycosis fungoides involving lymph nodes of inguinal region and lower limb     ( 202.15 )

• 191  Mycosis fungoides involving intrapelvic lymph nodes     ( 202.16 )

• 192  Mycosis fungoides involving spleen     ( 202.17 )

• 193  Mycosis fungoides involving lymph nodes of multiple sites     ( 202.18 )

• 194  Sezary's disease     ( 202.2 )

• 195  Sezary's disease unspecified site     ( 202.20 )

• 196  Sezary's disease involving lymph nodes of head face and neck     ( 202.21 )

• 197  Sezary's disease involving intrathoracic lymph nodes     ( 202.22 )

• 198  Sezary's disease involving intra-abdominal lymph nodes     ( 202.23 )

• 199  Sezary's disease involving lymph nodes of axilla and upper limb     ( 202.24 )

• 200  Sezary's disease involving lymph nodes of inguinal region and lower limb     ( 202.25 )

• 201  Sezary's disease involving intrapelvic lymph nodes     ( 202.26 )

• 202  Sezary's disease involving spleen     ( 202.27 )

• 203  Sezary's disease involving lymph nodes of multiple sites     ( 202.28 )

• 204  Malignant histiocytosis     ( 202.3 )

• 205  Malignant histiocytosis unspecified site     ( 202.30 )

• 206  Malignant histiocytosis involving lymph nodes of head face and neck     ( 202.31 )

• 207  Malignant histiocytosis involving intrathoracic lymph nodes     ( 202.32 )

• 208  Malignant histiocytosis involving intra-abdominal lymph nodes     ( 202.33 )

• 209  Malignant histiocytosis involving lymph nodes of axilla and upper limb     ( 202.34 )

• 210  Malignant histiocytosis involving lymph nodes of inguinal region and lower limb     ( 202.35 )

• 211  Malignant histiocytosis involving intrapelvic lymph nodes     ( 202.36 )

• 212  Malignant histiocytosis involving spleen     ( 202.37 )

• 213  Malignant histiocytosis involving lymph nodes of multiple sites     ( 202.38 )

• 214  Leukemic reticuloendotheliosis     ( 202.4 )

• 215  Leukemic reticuloendotheliosis unspecified site     ( 202.40 )

• 216  Leukemic reticuloendotheliosis involving lymph nodes of head face and neck     ( 202.41 )

• 217  Leukemic reticuloendotheliosis involving intrathoracic lymph nodes     ( 202.42 )

• 218  Leukemic reticuloendotheliosis involving intra-abdominal lymph nodes     ( 202.43 )

• 219  Leukemic reticuloendotheliosis involving lymph nodes of axilla and upper arm     ( 202.44 )

• 220  Leukemic reticuloendotheliosis involving lymph nodes of inguinal region and lower limb     ( 202.45 )

• 221  Leukemic reticuloendotheliosis involving intrapelvic lymph nodes     ( 202.46 )

• 222  Leukemic reticuloendotheliosis involving spleen     ( 202.47 )

• 223  Leukemic reticuloendotheliosis involving lymph nodes of multiple sites     ( 202.48 )

• 224  Letterer-siwe disease     ( 202.5 )

• 225  Letterer-siwe disease unspecified site     ( 202.50 )

• 226  Letterer-siwe disease involving lymph nodes of head face and neck     ( 202.51 )

• 227  Letterer-siwe disease involving intrathoracic lymph nodes     ( 202.52 )

• 228  Letterer-siwe disease involving intra-abdominal lymph nodes     ( 202.53 )

• 229  Letterer-siwe disease involving lymph nodes of axilla and upper limb     ( 202.54 )

• 230  Letterer-siwe disease involving lymph nodes of inguinal region and lower limb     ( 202.55 )

• 231  Letterer-siwe disease involving intrapelvic lymph nodes     ( 202.56 )

• 232  Letterer-siwe disease involving spleen     ( 202.57 )

• 233  Letterer-siwe disease involving lymph nodes of multiple sites     ( 202.58 )

• 234  Malignant mast cell tumors     ( 202.6 )

• 235  Malignant mast cell tumors unspecified site     ( 202.60 )

• 236  Malignant mast cell tumors involving lymph nodes of head face and neck     ( 202.61 )

• 237  Malignant mast cell tumors involving intrathoracic lymph nodes     ( 202.62 )

• 238  Malignant mast cell tumors involving intra-abdominal lymph nodes     ( 202.63 )

• 239  Malignant mast cell tumors involving lymph nodes of axilla and upper limb     ( 202.64 )

• 240  Malignant mast cell tumors involving lymph nodes of inguinal region and lower limb     ( 202.65 )

• 241  Malignant mast cell tumors involving intrapelvic lymph nodes     ( 202.66 )

• 242  Malignant mast cell tumors involving spleen     ( 202.67 )

• 243  Malignant mast cell tumors involving lymph nodes of multiple sites     ( 202.68 )

• 244  Other malignant neoplasms of lymphoid and histiocytic tissue : Peripheral T cell lymphoma     ( 202.7 )

• 245  Peripheral t cell lymphoma, unspecified site, extranodal and solid organ sites     ( 202.70 )

• 246  Peripheral t cell lymphoma, lymph nodes of head, face, and neck     ( 202.71 )

• 247  Peripheral t cell lymphoma, intrathoracic lymph nodes     ( 202.72 )

• 248  Peripheral t cell lymphoma, intra-abdominal lymph nodes     ( 202.73 )

• 249  Peripheral t cell lymphoma, lymph nodes of axilla and upper limb     ( 202.74 )

• 250  Peripheral t cell lymphoma, lymph nodes of inguinal region and lower limb     ( 202.75 )

• 251  Peripheral t cell lymphoma, intrapelvic lymph nodes     ( 202.76 )

• 252  Peripheral t cell lymphoma, spleen     ( 202.77 )

• 253  Peripheral t cell lymphoma, lymph nodes of multiple sites     ( 202.78 )

• 254  Other malignant lymphomas     ( 202.8 )

• 255  Other malignant lymphomas unspecified site     ( 202.80 )

• 256  Other malignant lymphomas involving lymph nodes of head face and neck     ( 202.81 )

• 257  Other malignant lymphomas involving intrathoracic lymph nodes     ( 202.82 )

• 258  Other malignant lymphomas involving intra-abdominal lymph nodes     ( 202.83 )

• 259  Other malignant lymphomas involving lymph nodes of axilla and upper limb     ( 202.84 )

• 260  Other malignant lymphomas involving lymph nodes of inguinal region and lower limb     ( 202.85 )

• 261  Other malignant lymphomas involving intrapelvic lymph nodes     ( 202.86 )

• 262  Other malignant lymphomas involving spleen     ( 202.87 )

• 263  Other malignant lymphomas involving lymph nodes of multiple sites     ( 202.88 )

• 264  Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue     ( 202.9 )

• 265  Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue unspecified site     ( 202.90 )

• 266  Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving lymph nodes of head face and neck     ( 202.91 )

• 267  Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving intrathoracic lymph nodes     ( 202.92 )

• 268  Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving intra-abdominal lymph nodes     ( 202.93 )

• 269  Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving lymph nodes of axilla and upper limb     ( 202.94 )

• 270  Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving lymph nodes of inguinal region and lower limb     ( 202.95 )

• 271  Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving intrapelvic lymph nodes     ( 202.96 )

• 272  Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving spleen     ( 202.97 )

• 273  Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving lymph nodes of multiple sites     ( 202.98 )

• 274  Multiple myeloma and immunoproliferative neoplasms     ( 203 )

• 275  Multiple myeloma     ( 203.0 )

• 276  Multiple myeloma, without mention of having achieved remission     ( 203.00 )

• 277  Multiple myeloma in remission     ( 203.01 )

• 278  Multiple myeloma, in relapse     ( 203.02 )

• 279  Plasma cell leukemia     ( 203.1 )

• 280  Plasma cell leukemia, without mention of having achieved remission     ( 203.10 )

• 281  Plasma cell leukemia in remission     ( 203.11 )

• 282  Plasma cell leukemia, in relapse     ( 203.12 )

• 283  Other immunoproliferative neoplasms     ( 203.8 )

• 284  Other immunoproliferative neoplasms, without mention of having achieved remission     ( 203.80 )

• 285  Other immunoproliferative neoplasms in remission     ( 203.81 )

• 286  Other immunoproliferative neoplasms, in relapse     ( 203.82 )

• 287  Lymphoid leukemia     ( 204 )

• 288  Lymphoid leukemia acute     ( 204.0 )

• 289  Acute lymphoid leukemia, without mention of having achieved remission     ( 204.00 )

• 290  Lymphoid leukemia acute in remission     ( 204.01 )

• 291  Acute lymphoid leukemia, in relapse     ( 204.02 )

• 292  Lymphoid leukemia chronic     ( 204.1 )

• 293  Chronic lymphoid leukemia, without mention of having achieved remission     ( 204.10 )

• 294  Lymphoid leukemia chronic in remission     ( 204.11 )

• 295  Chronic lymphoid leukemia, in relapse     ( 204.12 )

• 296  Lymphoid leukemia subacute     ( 204.2 )

• 297  Subacute lymphoid leukemia, without mention of having achieved remission     ( 204.20 )

• 298  Lymphoid leukemia subacute in remission     ( 204.21 )

• 299  Subacute lymphoid leukemia, in relapse     ( 204.22 )

• 300  Other lymphoid leukemia     ( 204.8 )

• 301  Other lymphoid leukemia, without mention of having achieved remission     ( 204.80 )

• 302  Other lymphoid leukemia in remission     ( 204.81 )

• 303  Other lymphoid leukemia, in relapse     ( 204.82 )

• 304  Unspecified lymphoid leukemia     ( 204.9 )

• 305  Unspecified lymphoid leukemia, without mention of having achieved remission     ( 204.90 )

• 306  Unspecified lymphoid leukemia in remission     ( 204.91 )

• 307  Unspecified lymphoid leukemia, in relapse     ( 204.92 )

• 308  Myeloid leukemia     ( 205 )

• 309  Myeloid leukemia acute     ( 205.0 )

• 310  Acute myeloid leukemia, without mention of having achieved remission     ( 205.00 )

• 311  Myeloid leukemia acute in remission     ( 205.01 )

• 312  Acute myeloid leukemia, in relapse     ( 205.02 )

• 313  Myeloid leukemia chronic     ( 205.1 )

• 314  Chronic myeloid leukemia, without mention of having achieved remission     ( 205.10 )

• 315  Myeloid leukemia chronic in remission     ( 205.11 )

• 316  Chronic myeloid leukemia, in relapse     ( 205.12 )

• 317  Myeloid leukemia subacute     ( 205.2 )

• 318  Subacute myeloid leukemia, without mention of having achieved remission     ( 205.20 )

• 319  Myeloid leukemia subacute in remission     ( 205.21 )

• 320  Subacute myeloid leukemia, in relapse     ( 205.22 )

• 321  Myeloid sarcoma     ( 205.3 )

• 322  Myeloid sarcoma, without mention of having achieved remission     ( 205.30 )

• 323  Myeloid sarcoma in remission     ( 205.31 )

• 324  Myeloid sarcoma, in relapse     ( 205.32 )

• 325  Other myeloid leukemia     ( 205.8 )

• 326  Other myeloid leukemia, without mention of having achieved remission     ( 205.80 )

• 327  Other myeloid leukemia in remission     ( 205.81 )

• 328  Other myeloid leukemia, in relapse     ( 205.82 )

• 329  Unspecified myeloid leukemia     ( 205.9 )

• 330  Unspecified myeloid leukemia, without mention of having achieved remission     ( 205.90 )

• 331  Unspecified myeloid leukemia in remission     ( 205.91 )

• 332  Unspecified myeloid leukemia, in relapse     ( 205.92 )

• 333  Monocytic leukemia     ( 206 )

• 334  Monocytic leukemia acute     ( 206.0 )

• 335  Acute monocytic leukemia, without mention of having achieved remission     ( 206.00 )

• 336  Monocytic leukemia acute in remission     ( 206.01 )

• 337  Acute monocytic leukemia, in relapse     ( 206.02 )

• 338  Monocytic leukemia chronic     ( 206.1 )

• 339  Chronic monocytic leukemia, without mention of having achieved remission     ( 206.10 )

• 340  Monocytic leukemia chronic in remission     ( 206.11 )

• 341  Chronic monocytic leukemia, in relapse     ( 206.12 )

• 342  Monocytic leukemia subacute     ( 206.2 )

• 343  Subacute monocytic leukemia, without mention of having achieved remission     ( 206.20 )

• 344  Monocytic leukemia subacute in remission     ( 206.21 )

• 345  Subacute monocytic leukemia, in relapse     ( 206.22 )

• 346  Other monocytic leukemia     ( 206.8 )

• 347  Other monocytic leukemia, without mention of having achieved remission     ( 206.80 )

• 348  Other monocytic leukemia in remission     ( 206.81 )

• 349  Other monocytic leukemia, in relapse     ( 206.82 )

• 350  Unspecified monocytic leukemia     ( 206.9 )

• 351  Unspecified monocytic leukemia, without mention of having achieved remission     ( 206.90 )

• 352  Unspecified monocytic leukemia in remission     ( 206.91 )

• 353  Unspecified monocytic leukemia, in relapse     ( 206.92 )

• 354  Other specified leukemia     ( 207 )

• 355  Acute erythremia and erythroleukemia     ( 207.0 )

• 356  Acute erythremia and erythroleukemia, without mention of having achieved remission     ( 207.00 )

• 357  Acute erythremia and erythroleukemia in remission     ( 207.01 )

• 358  Acute erythremia and erythroleukemia, in relapse     ( 207.02 )

• 359  Chronic erythremia     ( 207.1 )

• 360  Chronic erythremia, without mention of having achieved remission     ( 207.10 )

• 361  Chronic erythremia in remission     ( 207.11 )

• 362  Chronic erythremia, in relapse     ( 207.12 )

• 363  Megakaryocytic leukemia     ( 207.2 )

• 364  Megakaryocytic leukemia, without mention of having achieved remission     ( 207.20 )

• 365  Megakaryocytic leukemia in remission     ( 207.21 )

• 366  Megakaryocytic leukemia, in relapse     ( 207.22 )

• 367  Other specified leukemia     ( 207.8 )

• 368  Other specified leukemia, without mention of having achieved remission     ( 207.80 )

• 369  Other specified leukemia in remission     ( 207.81 )

• 370  Other specified leukemia, in relapse     ( 207.82 )

• 371  Leukemia of unspecified cell type     ( 208 )

• 372  Leukemia of unspecified cell type acute     ( 208.0 )

• 373  Acute leukemia of unspecified cell type, without mention of having achieved remission     ( 208.00 )

• 374  Leukemia of unspecified cell type acute in remission     ( 208.01 )

• 375  Acute leukemia of unspecified cell type, in relapse     ( 208.02 )

• 376  Leukemia of unspecified cell type chronic     ( 208.1 )

• 377  Chronic leukemia of unspecified cell type, without mention of having achieved remission     ( 208.10 )

• 378  Leukemia of unspecified cell type chronic in remission     ( 208.11 )

• 379  Chronic leukemia of unspecified cell type, in relapse     ( 208.12 )

• 380  Leukemia of unspecified cell type subacute     ( 208.2 )

• 381  Subacute leukemia of unspecified cell type, without mention of having achieved remission     ( 208.20 )

• 382  Leukemia of unspecified cell type subacute in remission     ( 208.21 )

• 383  Subacute leukemia of unspecified cell type, in relapse     ( 208.22 )

• 384  Other leukemia of unspecified cell type     ( 208.8 )

• 385  Other leukemia of unspecified cell type, without mention of having achieved remission     ( 208.80 )

• 386  Other leukemia of unspecified cell type in remission     ( 208.81 )

• 387  Other leukemia of unspecified cell type, in relapse     ( 208.82 )

• 388  Unspecified leukemia     ( 208.9 )

• 389  Unspecified leukemia, without mention of having achieved remission     ( 208.90 )

• 390  Unspecified leukemia in remission     ( 208.91 )

• 391  Unspecified leukemia, in relapse     ( 208.92 )